Celebrating World Immunization Week
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Hepatitis Awareness Hepatitis Awareness
JULY JULY Hepatitis Hepatitis Awareness Awareness But I will restore you to health and heal your wounds, But I will restore you to health and heal your wounds, declares the Lord. declares the Lord. - Jeremiah 30:17 - Jeremiah 30:17 July 28 is World Hepatitis Day. July 28 is World Hepatitis Day. The World Health Organization data show an estimated 325 million The World Health Organization data show an estimated 325 million people worldwide are living with chronic hepatitis B or chronic hepatitis C. people worldwide are living with chronic hepatitis B or chronic hepatitis C. Viral hepatitis caused more than one million deaths each year, a number Viral hepatitis caused more than one million deaths each year, a number comparable to deaths caused by tuberculosis and HIV combined. While comparable to deaths caused by tuberculosis and HIV combined. While deaths from tuberculosis and HIV have been declining, deaths from deaths from tuberculosis and HIV have been declining, deaths from hepatitis are increasing. Testing and preventive measures are crucial, hepatitis are increasing. Testing and preventive measures are crucial, as are education and awareness in communities like ours. as are education and awareness in communities like ours. At MLH: The Center for Advanced Liver Disease at the James D. Eason At MLH: The Center for Advanced Liver Disease at the James D. Eason Transplant Institute at Methodist University Hospital exclusively manages Transplant Institute at Methodist University Hospital exclusively manages all forms of liver disease. Our physicians are board certified in Transplant all forms of liver disease. Our physicians are board certified in Transplant Hepatology and Gastroenterology, and specialize in treatment of cirrhosis Hepatology and Gastroenterology, and specialize in treatment of cirrhosis and end stage liver disease, hepatitis, and cancers of the liver. -
World Hepatitis Day 2021 CAMPAIGN GUIDELINES
World Hepatitis Day 2021 CAMPAIGN GUIDELINES #WorldHepatitisDay worldhepatitisday.org CONTENTS CONTENTS PAGE Welcome to the World Hepatitis Day (WHD) campaign guidelines, 1. 3. Introduction Resources provided by World Hepatitis Alliance (WHA). World Hepatitis Day 03 Social media posts 14 Hepatitis Can’t Wait 04 Posters 15 Action can’t wait 05 Films 16 What we want to achieve 08 Zoom backgrounds 17 GIFs 18 2. Visual identity 4. Activations Logo 10 Join our virtual relay 20 We have produced a range of Colours 11 Fonts 12 Point to the time 21 multi-channel campaign resources Create a 30s reel 22 that you can use to raise awareness Frame your profile picture 23 in your communities and online. Sign the pledge 24 HEP CAN’T WAIT Campaign guidelines #WorldHepatitisDay 2 INTRODUCTION WORLD 325m Globally, 325 million people HEPATITIS DAY live with hepatitis Held on July 28 each year, WHD WHD is one of the World Health Organization’s officially mandated global public health days. It is is our day to raise awareness a day when the world comes together to raise of viral hepatitis. On this day we awareness of hepatitis, one of the most deadly aim to unite the global community and neglected diseases and health crises – one that is claiming a life every 30 seconds. Globally, to demand action from decision 325 million people live with hepatitis, with more makers globally to prioritise the than 1.1 million lives lost each year to hepatitis B elimination of viral hepatitis. and hepatitis C. Yet, we have the tools to eliminate the disease by 2030. -
The 10Th World Hepatitis Day 2020 — July 28, 2020
China CDC Weekly Announcements The 10th World Hepatitis Day 2020 — July 28, 2020 Zundong Yin1,# Viral hepatitis represents one of the most serious have decreased 97% from the pre-vaccine era public health threats in the world today. World prevalence to the current prevalence of 0.32% (12). Hepatitis Day takes place on July 28 every year and is Small-molecule, direct-acting hepatitis C antiviral an opportunity to step up national and international agents were included in China’s national medical efforts to control and prevent viral hepatitis and to insurance program last year (13). With properly- encourage action and engagement by individuals, administered antivirals, hepatitis C can be cured more partners, and the general public. July 28 was chosen for than 90% of the time (14). Prior to the introduction of the World Hepatitis Day because it is the birthday of universal hepatitis A vaccination, most people were Nobel-prize-winning scientist Dr. Baruch Blumberg, infected as children, but the incidence of hepatitis A who discovered hepatitis B virus (HBV) and developed declined markedly following the introduction of the a diagnostic test and vaccine for it (1). The World hepatitis A vaccine and improvements in sanitation and Health Organization (WHO)’s theme for World hygiene (15). Hepatitis Day 2020 is “Hepatitis-Free Future.” Although these achievements are impressive, there China has the heaviest burden of viral hepatitis in are major challenges remaining for prevention and the world. In 1979, approximately 9% to 10% of control of viral hepatitis in China. There are many people in China had chronic hepatitis B infection (2); adults in China living with hepatitis B because they in 1992, 3.2% of the population had hepatitis C (3); were infected during their birth or early childhood — and in the pre-hepatitis-A-vaccine era, outbreaks of before the widespread availability of hepatitis B hepatitis A occurred frequently throughout the vaccine. -
World Hepatitis Day 2017 WHO Guide on Advocacy and Communications
Department of HIV/AIDS, the Global Hepatitis Programme World Hepatitis Day 2017 WHO guide on advocacy and communications 1. Unique theme and objectives Since 2011, WHO has been collaborating with the World Hepatitis Alliance (WHA) – an umbrella civil society organization representing patient alliances – to coordinate the annual campaign for World Hepatitis Day. This year, we have agreed to commemorate the World Hepatitis Day under a joint theme: "Eliminate hepatitis". The 7th World Hepatitis Day on 28 July 2017 provides a historic opportunity to campaign to "Eliminate hepatitis", as envisioned in WHO's first “Global health sector strategy on viral hepatitis 2016–2021”, and included as the final target for hepatitis in the Sustainable Development Agenda 2030. Activities and awareness around World Hepatitis Day are designed to: build and leverage political engagement, following official endorsement of the global health sector strategy on viral hepatitis at the World Health Assembly 2016; showcase emerging national responses in high-burden countries; encourage actions by individuals and the public; and highlight the need for a greater global response as outlined in WHO's “Global hepatitis report, 2017”. In support of the "Eliminate hepatitis" campaign, WHO will release new information on the national responses in 28 of the highest-burden countries accounting for 70% of the global viral hepatitis burden. The countries are: Brazil, China, Egypt, India, Indonesia, Mongolia, Myanmar, Nigeria, Pakistan, Uganda, Viet Nam--11 countries that carry 50% of the global burden of chronic hepatitis B and C; and Cambodia, Cameroon, Colombia, Ethiopia, Georgia, Kyrgyzstan, Morocco, Nepal, Peru, Philippines, Sierra Leone, South Africa, Tanzania, Thailand, Ukraine, Uzbekistan, Zimbabwe--17 countries that also have high prevalence and developing national hepatitis responses. -
Promoting Hepatitis B & Liver Cancer Wellness in The
PROMOTING HEPATITIS B & LIVER CANCER WELLNESS IN THE GLOBAL WORKPLACE Developed by Asian Liver Center at Stanford University TABLE OF CONTENTS PAGE 02 THE BASICS OF HEPATITIS B AND LIVER CANCER PAGE 04 EMPLOYER CHECKLIST PAGE 07 CASE STUDIES PAGE 11 APPENDIX PAGE 12 CONTACT THE BASICS OF HEPATITIS B & LIVER CANCER BACKGROUND CHRONIC HEPATITIS B VIRUS (HBV) is the most common serious liver infection, and can lead to premature death from liver cancer or liver failure. However, it can be prevented with vaccination, and there are treatments as simple as a pill a day that would prevent disease progression. An inexpensive, one-time blood test will determine whether an individual is chronically infected and needs medical evaluation for monitoring or treatment. 1 IN 29 97 MILLION 1 IN 4 40 SECONDS 40 CHINA About 1 in 29 people in The burden of disease is Without appropriate Every 40 seconds, one the world (240 million greatest in Asia. China medical management, person dies from individuals) is living with alone has an estimated 97 1 in 4 of those chronically the complications of chronic HBV infection. million people chronically infected will die from this vaccine-preventable infected. liver cancer or liver failure. disease. RISK FACTOR HEALTH DISPARITY IMMIGRANT HEALTH LIVER CANCER A major risk factor in the Asian Americans make up Hepatitis B screening Liver cancer caused by U.S. for chronic HBV only 5% of the U.S. is NOT required before chronic HBV infection is infection is having been population, but account entry into the U.S. the second leading cause born in an endemic for more than 50% of of cancer death for Asian country where many are chronic HBV cases. -
Global Hepatitis Report 2017 ISBN 978-92-4-156545-5 © World Health Organization 2017 Some Rights Reserved
2017 REPORT, HEPATITIS GLOBAL TREAT TEST PREVENT GLOBAL HEPATITIS REPORT, 2017 Global hepatitis report 2017 ISBN 978-92-4-156545-5 © World Health Organization 2017 Some rights reserved. This work is available under the Creative Commons Attribution- NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/ licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non- commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specifi c organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Global Hepatitis Report 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. -
CDU NEWSLETTER a Monthly Newsletter Brought to You by the Wyoming Department of Health, Communicable Disease Unit
Autoimmune HepatitisC HepatitisB Hepatitis CDU NEWSLETTER A monthly newsletter brought to you by the Wyoming Department of Health, Communicable Disease Unit Monthly Theme: World Hepatitis Day JULY 2021 Top stories in this newsletter Hepatitis B Hepatitis C Overview and Overview and Statistics Sexual Health World Hepatitis Day The Wyoming Care Welcome to our new Statistics Considerations for July 28th and Prevention TB Controller, Sarah Individuals in the Planning Alliance will Hendricks! Polyamorous and/or meet July 30-31 in BDSM Communities Casper. webinar 7/20. CDU Monthly Webinar held the 3rd Tuesday of every month (check calendar below) CAPPA The Wyoming Care and Prevention Planning Alliance will be meeting in Casper July 30-31, 2021. Meeting details will be available at: https://health.wyo.gov/publichealth/communicable- disease-unit/cappa/ Considerations in Polyamorous and/or BDSM Communities webinar The John Hopkins Prevention Training Center will be providing a Sexual Health Considerations for Individuals in the Polyamorous and/or BDSM Communities webinar during our regularly scheduled CDU Monthly Webinar time on Tuesday, July 20th from 2-4 PM. Register at: https://courses.nnptc.org/class_information.html?id=3071 Curry International Tuberculosis Center Upcoming Curry Center Training Opportunities; August 3: Focus on LTBI (application deadline July13th) August 5: Tuberculosis Contact Investigation August 9-10: Tuberculosis Clinical Intensive August 24: Tuberculosis Nursing Workshop https://www.currytbcenter.ucsf.edu/trainings Save -
World Hepatitis Day: 28 July 2021
World Hepatitis Day: 28 July 2021 Theme “Hepatitis can’t wait” Hep Can't Wait Canto: TBD creative concept.pdf Website: TBD SOCO Stakeholders have increased awareness about the urgency of WHO 2030 targets with policymakers demonstrating political commitment for sustained and simplified hepatitis testing, prevention and treatment services more integrated into the primary health care services in the context of COVID-19 pandemic. Key messages WHO will collaborate with World Hepatitis alliance under a joint theme “Hepatitis can’t wait” conveying the urgency of efforts needed to eliminate hepatitis as a public health threat by 2030. Messages for the public: • People living with hepatitis unaware can’t wait for testing. • People living with hepatitis can’t wait for life saving treatments. • Expectant mothers can’t wait for hepatitis screening and treatment. • New-born babies can’t wait for birth dose vaccination. • People affected by hepatitis can’t wait to end stigma and discrimination. • Community organizations coping with hepatitis can’t wait for greater investment. • Decision-makers can’t wait any longer to make hepatitis elimination a reality through political will and funding. • Elimination of mother-to-child-transmission of HIV, hepatitis B, syphilis and Chagas can´t wait. Messages for top global leaders: • Commitment to support increased integration of hepatitis elimination, including integration withing existing programs. This includes increased commitment to quadruple elimination of mother-to-child-transmission of HIV, hepatitis B, syphilis and Chagas. • Commitment to increased funding for elimination of hepatitis as a public health threat. Funding will kick-start hepatitis elimination within universal health care delivery streams. -
Immunization in the Americas
Immunization in the Americas 2012 Summary Comprehensive Family Immunization Family and Community Health preface This year has been very important for global immunization. In May, the 65th World Health Assembly (WHA) endorsed a new Global Vaccines Action Plan (GVAP). This plan highlights immunization as a core component of the human right to health and as a shared responsibility between individuals, communities and governments. Building upon the 2006-2015 Global Immunization Vision and Strategy (GIVS), and recognizing immunization as a driver in the reduction of child mortality, the GVAP reiterates existing goals in the ght against vaccine-preventable diseases and sets new ones for the decade, with the aim of expanding the benets of vaccines to all people. Additionally, the 65th WHA ocially designated the last week of April, as the World Immunization Week (WIW). Recognizing the achievements of Vaccination Week in the Americas – and sister initiatives in other regions of the World Health Organization (WHO) – in promoting immunization, advancing equity in the use of vaccines, and enabling inter-country cooperation, as well as raising vaccination in the political agenda of governments, the Assembly called for the annual implementation of a WIW. In 2012, Vaccination Week in the Americas celebrated its 10th anniversary in synchronicity with all other Regions under the umbrella of what became the 1st WIW; more than 180 countries participated worldwide. With regards to measles and rubella, the GVAP set a goal to reduce 95% of measles-related deaths by 2015 and eliminate measles and rubella in at least ve of the six WHO Regions by 2020. In this context, 194 countries armed their commitment to achieving measles and rubella goals. -
July 28, 2016 Increased Hepatitis C Virus (HCV)
Morbidity and Mortality Weekly Report Weekly / Vol. 65 / No. 28 July 22, 2016 Increased Hepatitis C Virus (HCV) World Hepatitis Day — Detection in Women of Childbearing July 28, 2016 Age and Potential Risk for Vertical World Hepatitis Day, recognized on July 28, was established Transmission — United States and by the World Health Organization (WHO) to raise awareness Kentucky, 2011–2014 and promote understanding of viral hepatitis, the seventh leading cause of death worldwide (1). Together, hepatitis B Alaya Koneru, MPH1; Noele Nelson, MD1; Susan Hariri, PhD1; Lauren and hepatitis C are responsible for most of the 1.4 million Canary, MPH1; Kathy J. Sanders, MSN2; Justine F. Maxwell, MPH2; annual deaths attributed to viral hepatitis (1). In April 2016, Xiaohua Huang, MS3; John A.D. Leake, MD3; John W. Ward, MD1; Claudia Vellozzi, MD1 the 69th World Health Assembly adopted a Global Viral Hepatitis Strategy that aims to eliminate hepatitis B and Hepatitis C virus (HCV) infection is a leading cause of liver- hepatitis C as public health threats by 2030 (1). The strategy related morbidity and mortality (1). Transmission of HCV includes prevention and treatment targets that, when met, is primarily via parenteral blood exposure, and HCV can be will save millions of lives. transmitted vertically from mother to child. Vertical transmis- This issue of MMWR features a report revealing the sion occurs in 5.8% (95% confidence interval = 4.2%–7.8%) growing risk for perinatal transmission of hepatitis C virus of infants born to women who are infected only with HCV (HCV) in the United States, a risk most pronounced in areas and in up to twice as many infants born to women who are where HCV incidence is increasing among young adults and also infected with human immunodeficiency virus (HIV) (2) or women of childbearing age. -
Call to Action to Scale up Global Hepatitis Response
CALL TO ACTION TO SCALE UP GLOBAL HEPATITIS RESPONSE GLOBAL PARTNERS’ MEETING ON HEPATITIS (Convened by WHO in MarchC 2014 in Geneva) Background Viral hepatitis is now responsible for 1.4 million deaths every year (compared with 1.6 million deaths from HIV/AIDS, 1.3 million from tuberculosis and 0.6 million from malaria). Approximately, 500 million people are currently living with viral hepatitis and some 2 billion have been infected with hepatitis B virus. Most people with chronic hepatitis B or C are unaware of their infection and are at serious risk of developing cirrhosis or liver cancer, contributing to global increases in both of these chronic diseases. Millions of acute infections with hepatitis A virus and hepatitis E virus occur annually and result in tens of thousands of deaths almost exclusively in lower and middle-income countries. Hepatitis C is not preventable by vaccination, however, current treatment regimens offer high cure rates, which are expected to further improve with newer medicines. Such treatments must be made accessible to people who need them at affordable prices. Hepatitis B is preventable with a safe and effective vaccine, however, there are 240 million people living with chronic hepatitis B infection and available effective therapies could prevent cirrhosis and liver cancer among many of those infected. Preventive measures are not universally implemented, and equitable access to and availability of quality, effective, affordable and safe diagnostics and treatments for hepatitis B and C are lacking in many parts of the world, particularly in developing countries. The WHO Global Partners’ Meeting on HepatitisC united stakeholders as a global platform for better communication and collaboration to support a public-health, rights-based approach to viral hepatitis. -
Hepatitis B Control Through Immunization: a Reference Guide © World Health Organization 2014
WHO Hepatitis B Control Box 2: Whyasdf asdfsdfThrough Immunization: A Reference Guide Hepatitis B Control Through Immunization: A Reference Guide © World Health Organization 2014 WHO Library Cataloguing-in-Publication Data Hepatitis B Control Through Immunization: A Reference Guide 1. Hepatitis B – prevention and control. 2. Hepatitis B vaccines. 3. Immunization programs. 4. Regional health planning. I. World Health Organization Regional Office for the Western Pacific. ISBN 978 92 9061 669 6 (NLM Classification: WC 536) All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html). For WHO Western Pacific Regional Publications, request for permission to reproduce should be addressed to Publications Office, World Health Organization, Regional Office for the Western Pacific, P.O. Box 2932, 1000, Manila, Philippines (fax: +632 521 1036, email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.